These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 3646827)

  • 1. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
    Lembcke B; Grimm K; Lankisch PG
    Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal fat concentration in the differential diagnosis of steatorrhea.
    Bai JC; Andrüsh A; Matelo G; Martinez C; Vazquez H; Boerr L; Sambuelli A
    Am J Gastroenterol; 1989 Jan; 84(1):27-30. PubMed ID: 2912027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal fat concentration in patients with steatorrhea.
    Bo-Linn GW; Fordtran JS
    Gastroenterology; 1984 Aug; 87(2):319-22. PubMed ID: 6735076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of fecal fat concentrations as screening test in pancreatic insufficiency.
    Roberts IM; Poturich C; Wald A
    Dig Dis Sci; 1986 Oct; 31(10):1021-4. PubMed ID: 3757718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency.
    Gaskin KJ; Durie PR; Lee L; Hill R; Forstner GG
    Gastroenterology; 1984 Jan; 86(1):1-7. PubMed ID: 6689652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea.
    Walkowiak J; Lisowska A; Blask-Osipa A; Drzymała-Czyz S; Sobkowiak P; Cichy W; Breborowicz A; Herzig KH; Radzikowski A
    Pediatr Pulmonol; 2010 Mar; 45(3):249-54. PubMed ID: 20146370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
    Hahn JU; Kerner W; Maisonneuve P; Lowenfels AB; Lankisch PG
    Pancreas; 2008 Apr; 36(3):274-8. PubMed ID: 18362841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationalization of the quantitative determination of fecal fat].
    Bornschein W; Lessner F
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):333-42. PubMed ID: 4092655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic exocrine hypofunction in the wasting syndrome of end-stage renal disease.
    Sachs EF; Hurwitz FJ; Bloch HM; Milne FJ
    Am J Gastroenterol; 1983 Mar; 78(3):170-3. PubMed ID: 6829538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid steatocrit: a simple, rapid gravimetric method to determine steatorrhea.
    Amann ST; Josephson SA; Toskes PP
    Am J Gastroenterol; 1997 Dec; 92(12):2280-4. PubMed ID: 9399770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and significance of steatorrhea in patients with active Graves' disease.
    Goswami R; Tandon RK; Dudha A; Kochupillai N
    Am J Gastroenterol; 1998 Jul; 93(7):1122-5. PubMed ID: 9672342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin A absorption test. I. Pancreatic insufficiency and sprue (author's transl)].
    Schmidt G; Schröder G; Eisenberg K
    Med Klin; 1975 Oct; 70(43):1745-50. PubMed ID: 1186578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis, diagnosis and therapy of steatorrhea].
    Berndt H
    Dtsch Gesundheitsw; 1969 Jun; 24(26):1201-8. PubMed ID: 4913159
    [No Abstract]   [Full Text] [Related]  

  • 18. Faecal elastase-I: helpful in analysing steatorrhoea?
    Symersky T; van der Zon A; Biemond I; Masclee AA
    Neth J Med; 2004 Sep; 62(8):286-9. PubMed ID: 15588069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal alpha 1-antitrypsin clearance in the differential diagnosis of steatorrhea.
    Bai JC; Sugai E; Morán C; Sambuelli A; Vázquez H; Mazure R; Boerr L; Mackenzie D
    Acta Gastroenterol Latinoam; 1992; 22(2):95-8. PubMed ID: 1300854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests.
    Watkins JB; Klein PD; Schoeller DA; Kirschner BS; Park R; Perman JA
    Gastroenterology; 1982 May; 82(5 Pt 1):911-7. PubMed ID: 7060913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.